Navigation Links
Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Date:9/18/2007

KNOXVILLE, Tenn.--Provectus Pharmaceuticals, Inc. (OTCBB: PVCT) announced preliminary results of its Phase 1 clinical trial of Provecta for the treatment of metastatic melanoma, the most aggressive form of skin cancer. Provecta demonstrated minimal side effects, significant efficacy and bystander effect on melanoma tumors in stage III patients. The study evaluated safety and efficacy of Provecta in a total of 20 subjects at two sites in Australia.

In the study, Provecta was injected once into one to twenty tumors in each subject. In addition to these treated tumors, an additional one to three tumors were left untreated in each subject to allow assessment of a potential "bystander effect" resulting from immune system response to tumor treatment. A total of 114 tumors were injected and 39 bystander tumors were observed in the study. Subjects were followed for 4 to 27 weeks. Study treatments were well tolerated and elicited minimal side effects, the most common being mild to moderate pain at the injection site.

Results for all evaluable tumors were tabulated using the RECIST (Response Evaluation Criteria in Solid Tumors) approach, which objectively grades response for each subject based on change in the sum of the longest diameter for each of the subject's tumors vs. baseline. Subject outcome was scored in terms of complete response (CR -- complete tumor disappearance or negative histopathology), partial response (PR -- 30% or more tumor shrinkage), stable disease (SD -- 29% shrinkage to 20% growth), and progressive disease (PD -- greater than 20% growth).

At final evaluation after injection with a single dose of Provecta, the following results were obtained: 20% of subjects achieved CR of their injected tumors, 20% achieved PR, 35% achieved SD and 25% achieved PD, corresponding to an objective response (CR+PR) in 40% of subjects and local disease control (CR+PR+SD) in 75% of subjects. Among those subjects achieving an objective response
'/>"/>

Contact: Janet Vasquez
212-825-3210
Provectus Pharmaceuticals
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Sweet corn releases antioxidants on cooking
2. An International Growth Standard For Childs Releases By WHO
3. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
4. Eli Lilly Releases Digital Insulin Pen
5. Experimental treatment for Ebola Virus Shows promising results in mice
6. Hormone Deficiency Results In Miscarriage
7. Gleevec gets hopeful results
8. Breast Implants May Interfere With The Interpretation Of Mammogram Results
9. DNA Testing For More Accurate Results
10. Operating on a Beating Heart Yields Better Results For Blocked Heart Arteries
11. IVF results may be affected by stress and other related factors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...wire-USNewswire/ -- Today, the House of Representa..., Smith, Ellsworth and Lipinski amendment to the "...). The amendment maintains the current policy of p...efits packages that include abortion. It clarifies...ility credits and those who do not, can with their...
(Date:11/8/2009)...wire-USNewswire/ -- Pharmaceutical Research and Ma...nt Ken Johnson released the following statement re...We are disappointed, but not surprised by today,s ...rking Americans as well as nearly half of the memb... against the bill. ,, "While well intentioned, ...
(Date:11/8/2009)...o Sides With Working Families vs. Insurance Compan...ewswire/ -- On the heels of an historic late night...balanced health care reform bill, the Pennsylvania....S. representatives voted on HR 3962, the Affordab...tion, which passed Saturday evening by a vote of 2...
(Date:11/7/2009)...ewswire-USNewswire/ -- Speaker Nancy Pelosi spoke... the Affordable Health Care for America Act. The ... Below are the Speaker,s remarks. ,, "Madam Sp...t for our nation and for American families. For n...cal philosophy -- as far back as Teddy Roosevelt -...
(Date:11/7/2009)...e/ -- Calling this a "defining moment" for the Ame... J. James Rohack, M.D., today addressed medical st...dical specialty societies at the opening of the AM...h system reform will top the agenda. ,, (Logo: ...LOGO ) ,, "Over the next 72 hours, this AMA H...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
..., Israel, May 13 Lumenis Inc., a global,developer...d radiofrequency,devices for surgical, aesthetic, ...aunch of a Holmium Laser Enucleation of the Prosta...e of,clinical evidence suggests that HoLEP provide...
... proceeds despite non-compliance with California E...(CEQA)., LOS ANGELES, May 12 Providence Holy Cro...e planned expansion of its,Holy Cross Medical Cent...y held today appears to be an attempt to create,"f...
..., May 12 /PRNewswire-FirstCall/ - Med-Emerg Intern...revenue from continuing operations,for the three m...red to,$4.8 million for the same period in 2007 (a...ved to $179K,from a loss of ($106K) in 2007. The i...
..., Calif., May 12 (Nasdaq: WHRT, TSX:,WHT) World H...") announced,that the Toronto Stock Exchange ("TSX...g the eligibility for continued listing on the TSX...and,operating results, more specifically whether t...
...NT, Calif., May 12 Keck Graduate Institute (KGI),...t ceremony will feature,the graduation of KGI,s fi..., and the unveiling of KGI,s first donated artwork...ice president for academic affairs, dean of facult...
...E, N.Y., May 12 Fairbank Farms, a national,ground...elected ground beef,products produced at its Ashvi..., Shaw,s, BJ,s, and Wilson Farms retail outlets an.../13/08, 05/15/08, or a,"Julian date 124" on the pa...
Other Medicine News:Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 2Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 3Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 3Health News:WorldHeart Notified of TSX Delisting Review 2Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2
(Date:11/6/2009)..., Nov. 6 Philips Respironics appla... and Prevention (CDC) to raise awareness about an ...ufficiency. The CDC,s release of the first-ever go...es in sleeplessness is a milestone in quantifying ...g-time educator, industry leader and sleep therapy...
(Date:11/6/2009)...E PARK, N.C., Nov. 6 Chimerix, Inc...ailable antiviral therapeutics to address life-thr...pment of the company,s lead antiviral compound, CM...he Global Health Security Initiative (GHSI). CMX0...oped for the treatment of smallpox, as well as oth...
(Date:11/6/2009)... Caraco Pharmaceutical La...etorolac tromethamine ophthalmic solution, 0.5% fo... Administration (FDA) for Sun Pharma,s Abbreviated...74; opthalmic solution on the first day following ...herapeutically equivalent to Acular® Ophthalm...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 1Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 2Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 3Researchers describe implausible chemistry that produces herbicidal compound 8817 1Researchers describe implausible chemistry that produces herbicidal compound 8817 2
...,s Recombinant Protective Antigen Anthrax Vaccine ...gen,s Adjuvant, SCOTTSDALE, Ariz., Aug. 7 Immune... BioSciences Holdings, Inc.,(OTC Bulletin Board: I...Transfer Agreement (MTA) with VaxGen Inc. (Pink Sh...gen will receive the pharmaceutically active,ingre...
... for Antibiotics Eliminated in 87 Percent of Patie...s -, PRINCETON, N.J., Aug. 7 DEFLUX(R) (non-anim...r the treatment of,vesicoureteral reflux (VUR) in ...ry tract infections (UTIs) in children with VUR by...July issue of the Journal of,Laparoendoscopic & Ad...
Other Medicine Technology:ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 2DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 3DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 4
Gellhorn Pessary
Ring Pessary
Pyramis
...female urinary stress incontinence (SUI) with a mi...ic (BioArcTM SP) or a transobturator (BioArcTM TO)...em combining synthetic and biologic materials. It ...BioArc utilizes a polypropylene mesh for fixation ...
Medicine Products: